Correlation of Ultrasound and MRI Measurements of Quadratus Femoris Thickness and Ischiofemoral Distance in Clinically and Radiologically Diagnosed Ischiofemoral Impingement

NCT ID: NCT07198646

Last Updated: 2025-09-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-10

Study Completion Date

2025-04-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to evaluate the correlation between ultrasound measurements of quadratus femoris muscle thickness and ischiofemoral distance, as well as clinical parameters, with MRI measurements in patients diagnosed with ischiofemoral impingement (IFI) through MRI imaging and clinical examination. The main questions it aims to answer are: Is there a correlation between ultrasound and MRI measurements of quadratus femoris muscle thickness and ischiofemoral distance in patients with clinically and radiologically confirmed IFI? How do clinical parameters relate to ultrasound and MRI findings in these patients? What is the intra- and inter-rater reliability of ultrasound measurements for these parameters? Participants will undergo ultrasound measurement of quadratus femoris muscle thickness and ischiofemoral distance, assessment of clinical parameters related to ischiofemoral impingement, and measurements performed twice by two independent raters to assess intra- and inter-rater reliability. Researchers will compare ultrasound and MRI measurements as well as clinical parameters to determine if ultrasound can serve as a reliable and cost-effective alternative for diagnosing ischiofemoral impingement.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Ischiofemoral impingement (IFI) was first described in 1977 by Karl A. Johnson, and his study is widely regarded as the first clinical definition of the syndrome. IFI is defined as an extra-articular hip impingement syndrome resulting from the narrowing of the space between the ischium and the lesser trochanter, leading to compression of the quadratus femoris muscle and surrounding soft tissues, thereby causing clinical symptoms.

IFI findings are associated with edema and irritation of the quadratus femoris muscle, as well as secondary atrophic fatty degeneration in chronic cases. The primary symptom is posterior and lateral hip pain, often exacerbated by physical activity. Due to the close anatomical relationship between the quadratus femoris muscle and the sciatic nerve, irritation of the nerve may lead to pain radiating anteriorly, to the posterior thigh, and distally to the knee.

The etiology of IFI is multifactorial, involving congenital anatomical variations, post-traumatic sequelae, postoperative changes following hip surgery, and primary hip joint pathologies. Additional factors, such as femoral anteversion, acetabular retroversion, and abductor or adductor insufficiencies, may also contribute to its pathogenesis. The exact prevalence of IFI remains unknown, but it has been reported to be more common in females than in males, with a female-to-male ratio of approximately 3:1. This higher incidence in females is attributed to gender differences in pelvic morphology and a narrower ischiofemoral space. While IFI typically affects middle-aged and older adults, it has been observed across a wide age range (30-70 years). Although IFI generally presents unilaterally, bilateral involvement has been reported in 25-40% of cases, with no consensus in the literature regarding side predominance. The diagnosis of IFI requires a combination of detailed patient history, physical examination, and imaging techniques. Clinical tests such as the long-stride walking test and the ischiofemoral impingement test play a significant role in diagnosis, while MRI is considered the gold-standard imaging modality for confirmation.

The present study aims to investigate the correlation between ultrasound measurements and MRI findings in patients diagnosed with IFI through MRI and clinical examination. Specifically, ultrasound measurements of quadratus femoris muscle thickness and ischiofemoral distance will be evaluated for their consistency with MRI findings. Additionally, clinical parameters related to IFI will be assessed to explore their association with imaging results. The primary objective of this study is to determine the feasibility of using ultrasound, a more cost-effective imaging method, as an alternative diagnostic tool for IFI. The hypothesis is that by establishing a reliable correlation between ultrasound and MRI findings, it may be possible to implement a lower-cost and more accessible diagnostic approach for this condition.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Pain Chronic Impingement Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients older than 18 years and younger than 65 years.
2. Patients diagnosed by MRI
3. Those with a body mass index below 25 kg/m2
4. those with hip pain or positive physical examination tests

Exclusion Criteria

1. Sciatic nerve damage detected on EMG
2. Patients with operative ischiofemoral decompression
3. Corticosteroid or any injection to the hip in the last 3 months
4. History of peripheral nerve damage
5. Femoroacetabular impingement
6. Pregnancy
7. Malignancy
8. Inflammatory pathologies: rheumatic, septic
9. Coxarthrosis-Kelgren-Lawrence grade 3-4
10. Those who have undergone hip arthroplasty/surgery
11. Causes of lumbar radiculopathy, spondylolisthesis
12. Patients with increased femoral anteversion - patients with increased hip internal rotation (Toe-in)
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kutay Can ÇAMLICA

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kutay Can ÇAMLICA

Resident Physician, Department of Physical Medicine and Rehabilitation

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jülide Öncü Alptekin, Professor

Role: STUDY_DIRECTOR

Sisli Hamidiye Etfal Training and Research Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seyrantepe Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul, Turkey

Istanbul, sarıyer, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4500

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Graded Motor Imagery in Impingement
NCT06865001 ACTIVE_NOT_RECRUITING NA
Ultrasonograpy in Hemiplegic Patients
NCT06706063 ACTIVE_NOT_RECRUITING